Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Free Cash Flow (2016 - 2025)

Aethlon Medical filings provide 15 years of Free Cash Flow readings, the most recent being -$1.7 million for Q1 2025.

  • On a quarterly basis, Free Cash Flow rose 35.01% to -$1.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $804814.0, a 107.75% increase, with the full-year FY2025 number at -$7.6 million, up 26.35% from a year prior.
  • Free Cash Flow hit -$1.7 million in Q1 2025 for Aethlon Medical, down from $2.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $2.2 million in Q3 2024 to a low of -$3.6 million in Q3 2022.
  • Median Free Cash Flow over the past 5 years was -$2.4 million (2023), compared with a mean of -$2.0 million.
  • Biggest five-year swings in Free Cash Flow: plummeted 88.55% in 2022 and later soared 184.17% in 2024.
  • Aethlon Medical's Free Cash Flow stood at -$2.8 million in 2021, then grew by 24.26% to -$2.1 million in 2022, then dropped by 13.51% to -$2.4 million in 2023, then skyrocketed by 184.17% to $2.0 million in 2024, then crashed by 183.16% to -$1.7 million in 2025.
  • The last three reported values for Free Cash Flow were -$1.7 million (Q1 2025), $2.0 million (Q4 2024), and $2.2 million (Q3 2024) per Business Quant data.